Atlas Trials

Phase I Study of Perifosine + Sorafenib for Patients With Advanced Cancers

Clinical trial NCT00398814 · COMPLETED

Trial details

NCT number
NCT00398814
Sponsor
AEterna Zentaris
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Renal CancerTumors
Start date
2006-10-01
Primary completion
2011-09-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.